GARS Antikörper (AA 35-305)
Kurzübersicht für GARS Antikörper (AA 35-305) (ABIN7091173)
Target
Alle GARS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    
- 
                                            
Bindungsspezifität
 - AA 35-305
 - 
                                            
Homologie
 - Human
 - 
                                            
Immunogen
 - Recombinant human GARS between 35-305 amino acids.
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - WB 1:300-5000
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Konzentration
 - 0.5 μg/μL
 - 
                                            
Buffer
 - 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
 - 
                                            
Konservierungsmittel
 - ProClin
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - 4 °C,-20 °C
 - 
                                            
Informationen zur Lagerung
 - Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
 - 
                                            
Haltbarkeit
 - 12 months
 
 - 
                                            
 - 
    
- GARS (Glycyl-tRNA Synthetase (GARS))
 - 
                                            
Andere Bezeichnung
 - GARS
 - 
                                            
Hintergrund
 - 
                        
Synonyms: AP 4 A synthetase, Charcot Marie Tooth neuropathy 2D, Charcot Marie Tooth neuropathy neuronal type D, CMT2D, Diadenosine tetraphosphate synthetase, DSMAV, EC 6.1.1.14, Glycine tRNA ligase, Glycyl tRNA synthetase, GlyRS, HMN5, SMAD1, GARS_HUMAN.
Background: GARS synthetase catalyzes the ligation of glycine with glycyl-tRNA using ATP and its mutation induces Charcot-Marie-Tooth (CMT) disease.
 - 
                                            
Gen-ID
 - 2617
 - 
                                            
UniProt
 - P41250
 - 
                                            
Pathways
 - Ribonucleoside Biosynthetic Process
 
Target
 -